MedPath

Norgestimate and ethinyl estradiol

These highlights do not include all the information needed to use NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS USP safely and effectively. See full prescribing information for NORGESTIMATE AND ETHINYL ESTRADIOL TABLETS USP. NORGESTIMATE and ETHINYL ESTRADIOL tablets USP, for oral use Initial U.S. Approval: 1989

Approved
Approval ID

b936a6fb-27ed-44de-9199-8c656bcd366e

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 9, 2024

Manufacturers
FDA

Naari Pte Limited

DUNS: 659345996

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Norgestimate and ethinyl estradiol

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code79929-009
Application NumberANDA200383
Product Classification
M
Marketing Category
C73584
G
Generic Name
Norgestimate and ethinyl estradiol
Product Specifications
Effective DateJanuary 9, 2024
FDA Product Classification

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Norgestimate and ethinyl estradiol - FDA Drug Approval Details